Phacilitate Leaders World

General

General

The Clinician's Perspective on Patient Access

The realities of administering advanced therapies in the clinic is our industry's next big challenge. So, what is the clinician's perspective on what's needed to effectively and safely bring advanced therapies to patients?

View the video


 

Demystifying the Common Technical Document

The Common Technical Document can sometimes be a bit daunting. As a fundamental part of the approval process for your product, whether you are a huge multinational corporation or a small biotech company, it is essential to know how to use the CTD.

Chris Bravery of Advanced Biologicals gave us some insights on how to successfully complete the CTD. 

View the guide 


 

Emily Whitehead Foundation and Phacilitate to Hold Yacht Party Fundraiser at Phacilitate Leaders World in Miami

In an effort to bring more awareness to pediatric cancer immunotherapy research, the Emily Whitehead Foundation and London-based Phacilitate are joining together to hold a one of a kind fundraising event in Miami, Florida on January 24, 2019.

Read the press release


 

Just Copy and Paste is Not Operable: 3D Bioprinting of Human Scale Organs for Clinical Use

3D bioprinting is a nascent but promising digital and biotechnological game changer in the healthcare industry. A guest post by Senem Simsek, PhD.

Read the article


 

Registration is live for world’s largest advanced therapies and stem cell event with 2,000 attendees expected at Hyatt Regency Miami in January 2019

The wait is over! Global leaders in advanced therapies, regenerative medicine and the stem cell field can register now for the co-located Phacilitate Leaders World and World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-25, 2019. Early Bird Rate Ends November 15th, 2018!

Find out more


 

The Phacilitate Leaders World and World Stem Cell Summit announces renewed partnership

Based on the success of the co-located World Stem Cell Summit and Phacilitate Leaders World conferences in January 2018, the Regenerative Medicine Foundation (RMF) and Phacilitate announced they will partner again, combining four major international meetings at the Hyatt Regency Miami, January 22-25, 2019.

Read the press release


 

Increasing access to cell and gene therapies: the potential of outcome-based annuity payments

Could outcome-based annuity payments, in which cell and gene therapies are paid for over-time as benefits materialise, increase patient access to these innovative and potentially revolutionary therapies?

Find out here


 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK